Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Oosterhuis

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Fundamental & Clinical Pharmacology|October 30, 1998
A study comparing biopharmaceutic characteristics of four once daily controlled release diltiazem preparationsM G Hendriks, P Dogterom, J T Ebels, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1989
A phase I pharmacokinetic study of 21-day continuous infusion mitoxantroneJ Greidanus, E G de Vries, N H Mulder, et al.
Journal of Clinical Pharmacology|February 24, 2001
Steady-state pharmacodynamics and pharmacokinetics of warfarin in the presence and absence of telmisartan in healthy male volunteersJ Stangier, C A Su, M G Hendriks, et al.
Journal of Clinical Pharmacology|February 24, 2001
The effect of telmisartan on the steady-state pharmacokinetics of digoxin in healthy male volunteersJ Stangier, C A Su, M G Hendriks, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Clinical pharmacokinetics and tolerability of alpidem in healthy subjects given increasing single dosesJ H Jonkman, G Bianchetti, G Grasmeijer, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|July 8, 1998
Validated method for the determination of idazoxan in human plasma by liquid chromatography with tandem mass spectrometric detectionN C van de Merbel, A P Tinke, W D van Dongen, et al.
British Journal of Clinical Pharmacology|June 1, 1989
Effects of alpha-interferon on theophylline pharmacokinetics and metabolismJ H Jonkman, K G Nicholson, P R Farrow, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 13, 1998
Pharmacokinetics of [14C]-labelled Losigamone and enantiomers after oral administration to healthy subjectsP A Peeters, J J Van Lier, N Van De Merbel, et al.
Chronobiologia|January 1, 1988
Dosing time and sex-related differences in the pharmacokinetics of cefodizime and in the circadian cortisol rhythmJ H Jonkman, A Reinberg, B Oosterhuis, et al.
European Journal of Clinical Pharmacology|June 24, 1999
CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differencesW J Tamminga, J Wemer, B Oosterhuis, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Fundamental & Clinical Pharmacology|October 30, 1998
A study comparing biopharmaceutic characteristics of four once daily controlled release diltiazem preparationsM G Hendriks, P Dogterom, J T Ebels, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1989
A phase I pharmacokinetic study of 21-day continuous infusion mitoxantroneJ Greidanus, E G de Vries, N H Mulder, et al.
Journal of Clinical Pharmacology|February 24, 2001
Steady-state pharmacodynamics and pharmacokinetics of warfarin in the presence and absence of telmisartan in healthy male volunteersJ Stangier, C A Su, M G Hendriks, et al.
Journal of Clinical Pharmacology|February 24, 2001
The effect of telmisartan on the steady-state pharmacokinetics of digoxin in healthy male volunteersJ Stangier, C A Su, M G Hendriks, et al.
European Journal of Clinical Pharmacology|January 1, 1991
Clinical pharmacokinetics and tolerability of alpidem in healthy subjects given increasing single dosesJ H Jonkman, G Bianchetti, G Grasmeijer, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|July 8, 1998
Validated method for the determination of idazoxan in human plasma by liquid chromatography with tandem mass spectrometric detectionN C van de Merbel, A P Tinke, W D van Dongen, et al.
British Journal of Clinical Pharmacology|June 1, 1989
Effects of alpha-interferon on theophylline pharmacokinetics and metabolismJ H Jonkman, K G Nicholson, P R Farrow, et al.
European Journal of Drug Metabolism and Pharmacokinetics|June 13, 1998
Pharmacokinetics of [14C]-labelled Losigamone and enantiomers after oral administration to healthy subjectsP A Peeters, J J Van Lier, N Van De Merbel, et al.
Chronobiologia|January 1, 1988
Dosing time and sex-related differences in the pharmacokinetics of cefodizime and in the circadian cortisol rhythmJ H Jonkman, A Reinberg, B Oosterhuis, et al.
European Journal of Clinical Pharmacology|June 24, 1999
CYP2D6 and CYP2C19 activity in a large population of Dutch healthy volunteers: indications for oral contraceptive-related gender differencesW J Tamminga, J Wemer, B Oosterhuis, et al.
Pageof 6